| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 13.27▲ | 13.28▲ | 13.28▲ | 13.31▼ | 13.16▲ |
| MA10 | 13.27▲ | 13.30▼ | 13.30▼ | 13.32▼ | 13.06▲ |
| MA20 | 13.29▼ | 13.30▼ | 13.31▼ | 13.19▲ | 12.97▲ |
| MA50 | 13.31▼ | 13.24▲ | 13.21▲ | 13.07▲ | 12.98▲ |
| MA100 | 13.17▲ | 13.12▲ | 13.10▲ | 12.97▲ | 13.17▲ |
| MA200 | 13.05▲ | 13.02▲ | 13.00▲ | 12.95▲ | 13.35▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | -0.009▼ | -0.012▼ | 0.005▲ | 0.050▲ |
| RSI | 50.500▲ | 50.818▲ | 51.467▲ | 58.666▲ | 64.027▲ |
| STOCH | 33.333 | 38.615 | 40.303 | 57.642 | 76.087 |
| WILL %R | -42.857 | -54.545 | -54.545 | -35.706 | -21.142▲ |
| CCI | -2.456 | -29.167 | -22.695 | 29.458 | 156.967▲ |
|
Wednesday, November 12, 2025 05:51 AM
- Rare disease commercial veteran Mr. Grabow to lead Immix’s U.S. launch and commercial buildout for NXC-201 in relapsed/refractory AL Amyloidosis, a serious, rare, blood disease with no currently ...
|
|
Thursday, November 06, 2025 10:39 AM
Immix Biopharma, Inc. is building strength in its pipeline with impressive early signals in AL amyloidosis. Learn more about IMMX stock here.
|
|
Monday, November 03, 2025 12:45 AM
Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), the global leader in relapsed/refractory AL Amyloidosis, today announced that Phase 1/2 interim results from its U.S. NXC-201 ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/11/25 | 13.26 | 13.32 | 13.25 | 13.29 | 21,500 |
| 13/11/25 | 13.31 | 13.33 | 13.31 | 13.31 | 12,700 |
| 12/11/25 | 13.31 | 13.35 | 13.21 | 13.34 | 33,500 |
| 11/11/25 | 13.37 | 13.37 | 13.32 | 13.36 | 2,300 |
| 10/11/25 | 13.18 | 13.30 | 13.18 | 13.26 | 14,300 |
| 07/11/25 | 13.30 | 13.35 | 13.18 | 13.22 | 40,600 |
| 06/11/25 | 13.40 | 13.4455 | 13.36 | 13.36 | 62,857 |
| 05/11/25 | 13.31 | 13.42 | 13.31 | 13.41 | 21,200 |
| 04/11/25 | 13.28 | 13.38 | 13.25 | 13.35 | 12,000 |
| 03/11/25 | 13.18 | 13.30 | 13.18 | 13.26 | 15,200 |
|
|
||||
|
|
||||
|
|